Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tanaka

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Thoracic Cancer|October 25, 2022
Early recurrence factors in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapyYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2022
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case seriesYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Molecular and Clinical Oncology|February 19, 2021
Postoperative delirium in patients undergoing tumor resection with reconstructive surgery for oral cancerNozomu Takahashi, Akimitsu Hiraki, Kenta Kawahara, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 12, 2013
A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinomaKenta Kawahara, Hideki Nakayama, Masashi Nagata, et al.
Thoracic Cancer|March 30, 2023
Influencing factors of efficacy and long-term use of amrubicin in patients with small cell lung cancerYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
International Journal of Oncology|January 24, 2014
Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cellsYoshihiro Nakagawa, Hideki Nakayama, Masashi Nagata, et al.
Molecular and Clinical Oncology|June 23, 2016
Sentinel lymph node biopsy reduces the incidence of secondary neck metastasis in patients with oral squamous cell carcinomaAkimitsu Hiraki, Daiki Fukuma, Masashi Nagata, et al.
Thoracic Cancer|August 19, 2021
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadowsYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Thoracic Cancer|January 6, 2022
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancerYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Cancer Science|December 6, 2011
Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinomaTakuya Tanaka, Hideki Nakayama, Yoshihiro Yoshitake, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Thoracic Cancer|October 25, 2022
Early recurrence factors in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapyYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2022
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case seriesYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Molecular and Clinical Oncology|February 19, 2021
Postoperative delirium in patients undergoing tumor resection with reconstructive surgery for oral cancerNozomu Takahashi, Akimitsu Hiraki, Kenta Kawahara, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 12, 2013
A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinomaKenta Kawahara, Hideki Nakayama, Masashi Nagata, et al.
Thoracic Cancer|March 30, 2023
Influencing factors of efficacy and long-term use of amrubicin in patients with small cell lung cancerYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
International Journal of Oncology|January 24, 2014
Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cellsYoshihiro Nakagawa, Hideki Nakayama, Masashi Nagata, et al.
Molecular and Clinical Oncology|June 23, 2016
Sentinel lymph node biopsy reduces the incidence of secondary neck metastasis in patients with oral squamous cell carcinomaAkimitsu Hiraki, Daiki Fukuma, Masashi Nagata, et al.
Thoracic Cancer|August 19, 2021
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadowsYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Thoracic Cancer|January 6, 2022
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancerYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.
Cancer Science|December 6, 2011
Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinomaTakuya Tanaka, Hideki Nakayama, Yoshihiro Yoshitake, et al.
Pageof 6